Avatar Medical, an award-winning company advancing medical imaging from visualization to clinical understanding, announced on 8 October 2026 that its Avatar Medical Vision software platform has received CE Marking for visualizing CT and MR images in 3D and VR for surgical planning and intervention. The milestone enables commercialization in Europe, but its significance goes beyond a single regulatory approval: it marks the first time any software has been CE-Marked for use with a glasses-free 3D medical display. For clinicians, that distinction could reshape how medical images are viewed and shared in everyday practice.
Until now, immersive 3D visualization of patient anatomy has typically required a virtual reality headset. That approach offers depth perception, but it also introduces practical obstacles in clinical environments: headsets must be cleaned between uses, cables can tangle or limit movement, and hardware occasionally fails. Avatar Medical Vision, when paired with a glasses-free 3D display, delivers the same depth perception without requiring anyone to wear equipment on their head. As a result, surgeons and patients can view lifelike 3D anatomy together during consultations, and surgical teams can incorporate 3D visualization into planning sessions without the logistical burden of headsets. The company notes that with no headsets to clean, no cables to manage and no occasionally unreliable hardware, glasses-free 3D is much better suited to everyday clinical settings, from consultations to surgical planning.
The regulatory clearance also strengthens Avatar Medical's commercial position. Building on Avatar Medical Vision's initial CE marking in 2025, this latest milestone specifically enables commercialization of its glasses-free 3D capabilities in Europe. Combined with existing regulatory clearances in both Europe and the United States, the company can now pursue broader adoption across two major healthcare markets. That dual-market foundation matters because it allows Avatar Medical to scale a single platform across regions rather than tailoring separate products for each regulatory jurisdiction. More details about the announcement are available click here.
At a broader level, the CE Marking advances Avatar Medical's stated goal of Visual Intelligence for Surgery throughout the care journey. The company's focus extends from patient consultations to surgical planning and the operating room. This milestone strengthens two key steps of that journey—consultation and surgical planning—by making patient-specific anatomy easier to understand across multiple specialties. Avatar Medical Vision converts CT and MRI scans into interactive, lifelike 3D visualizations instantly and without segmentation, giving clinicians a more intuitive way to understand anatomy, plan procedures, collaborate and communicate with patients. Removing the headset from the equation could accelerate adoption among clinicians who have been hesitant to incorporate VR into routine workflows.
Founded in 2020, Avatar Medical originated from research conducted at Institut Curie and Institut Pasteur. It works with more than 20 hospitals across the United States and Europe. Its technology products are both FDA-cleared and CE-marked. Learn more at avatarmedical.ai, and visit the press kit for additional resources.
